Cargando…

Virological Markers in Epstein–Barr Virus-Associated Diseases

Epstein–Barr virus (EBV) is an oncogenic virus infecting more than 95% of the world’s population. After primary infection—responsible for infectious mononucleosis in young adults—the virus persists lifelong in the infected host, especially in memory B cells. Viral persistence is usually without clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lupo, Julien, Truffot, Aurélie, Andreani, Julien, Habib, Mohammed, Epaulard, Olivier, Morand, Patrice, Germi, Raphaële
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051789/ https://www.ncbi.nlm.nih.gov/pubmed/36992365 http://dx.doi.org/10.3390/v15030656

Ejemplares similares

Comparison of Elecsys and Liaison immunoassays to determine Epstein–Barr virus serological status using further diagnostic approaches to clarify discrepant results
por: Lupo, Julien, et al.
Publicado: (2022)

Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine
por: Jean-Pierre, Vincent, et al.
Publicado: (2021)

Lytic EBV infection investigated by detection of Soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD
por: Habib, Mohammed, et al.
Publicado: (2017)

SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy
por: Truffot, Aurélie, et al.
Publicado: (2021)

Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000–2016
por: Fourcade, Grégoire, et al.
Publicado: (2017)

Evaluation of six commercial SARS-CoV-2 rapid antigen tests in nasopharyngeal swabs: Better knowledge for better patient management?
por: Andreani, Julien, et al.
Publicado: (2021)

Sustained virological and biochemical responses to lamivudine and adefovir dipivoxil combination in a chronic hepatitis B infection despite mutations conferring resistance to both drugs
por: Larrat, Sylvie, et al.
Publicado: (2008)

High Predictive Value of the Soluble ZEBRA Antigen (Epstein-Barr Virus Trans-Activator Zta) in Transplant Patients with PTLD
por: Lupo, Julien, et al.
Publicado: (2022)

Difference in cytokine production and cell cycle progression induced by Epstein-Barr virus Lmp1 deletion variants in Kmh2, a Hodgkin lymphoma cell line
por: Sueur, Charlotte, et al.
Publicado: (2014)

Epstein-Barr virus: the molecular virology and the associated diseases
por: Murata, Takayuki
Publicado: (2023)

Fatal case of acute gastroenteritis with multiple viral coinfections()
por: Lupo, Julien, et al.
Publicado: (2016)

Structural basis of DNA methylation-dependent site selectivity of the Epstein–Barr virus lytic switch protein ZEBRA/Zta/BZLF1
por: Bernaudat, Florent, et al.
Publicado: (2021)

Early Virological and Immunological Events in Asymptomatic Epstein-Barr Virus Infection in African Children
por: Jayasooriya, Shamanthi, et al.
Publicado: (2015)

Clinical, virologic, and serologic evidence of Epstein-Barr virus infection in association with childhood pneumonia()
por: Andiman, Warren A., et al.
Publicado: (1981)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Epstein-Barr Virus and Neurological Diseases
por: Zhang, Nan, et al.
Publicado: (2022)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Markers of Epstein-Barr Virus Infection in Patients with Multiple Sclerosis
por: Debuysschere, Cyril, et al.
Publicado: (2023)

Epstein-Barr virus infection and clinical outcome in breast cancer patients correlate with immune cell TNF-α/IFN-γ response
por: Marrão, Gina, et al.
Publicado: (2014)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

Epstein-Barr Virus Antibodies in Kawasaki Disease
por: Lee, Soon-Ju, et al.
Publicado: (2006)

Epstein-Barr Virus (Infectious Disease and Therapy)
por: Pagano, Joseph
Publicado: (2006)

Epstein-Barr Virus in Systemic Autoimmune Diseases
por: Draborg, Anette Holck, et al.
Publicado: (2013)

Chronic Active Epstein–Barr Virus Disease
por: Kimura, Hiroshi, et al.
Publicado: (2017)

Epstein-Barr Virus and Systemic Autoimmune Diseases
por: Houen, Gunnar, et al.
Publicado: (2021)

Combined Linkage and Association Studies Show that HLA Class II Variants Control Levels of Antibodies against Epstein-Barr Virus Antigens
por: Pedergnana, Vincent, et al.
Publicado: (2014)

Epstein-Barr virus as a marker of biological aggressiveness in breast cancer
por: Mazouni, C, et al.
Publicado: (2011)

The expression of renal Epstein-Barr virus markers in patients with lupus nephritis
por: YU, XIAO-XIA, et al.
Publicado: (2014)

Age-related Epstein–Barr virus-positive mucocutaneous ulcer: a case report
por: Magalhaes, Marco, et al.
Publicado: (2015)

Epstein-Barr Virus and Human Cancer
por: Young, Lawrence
Publicado: (2002)

An Epstein-Barr virus-associated superantigen
Publicado: (1996)

Macular Amyloidosis and Epstein-Barr Virus
por: Nahidi, Yalda, et al.
Publicado: (2016)

Epstein-Barr virus infection mechanisms
por: Chesnokova, Liudmila S., et al.
Publicado: (2014)

Epstein-Barr Virus Neurologic Complications
por: Millichap, J. Gordon
Publicado: (2015)

Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fg759bv2giejdjchm6q5klof97